Diabetes ‘action plan’ aims to tackle huge rise in Leicester

Posted by ap507 at Mar 01, 2018 02:54 PM |
Leicester becomes first UK city to launch a dedicated diabetes action plan

Issued by the Leicester Diabetes Centre on 1 March

Leicester has become the first UK city to launch a dedicated diabetes action plan as part of a global drive to combat an alarming rise in diagnoses of the condition.

Latest figures have revealed that diagnoses of diabetes have more than doubled in the UK in the past 20 years, with Leicester enduring one of the highest diabetes prevalence rates in the country at 8.98 per cent, well above the national average of 6.4 per cent

With an estimated 28,253 people in the city living with diabetes, Leicester has signed up to the Cities Changing Diabetes programme, a global initiative to tackle the rising trend of type 2 diabetes in urban areas.

Professor Melanie Davies CBE, Professor of Diabetes Medicine at the University of Leicester and Director of the Leicester Diabetes Centre, said: “Type 2 diabetes represents a significant challenge, especially in our multi-ethnic city, but a challenge we are committed to meeting.

“The recent figures suggest there are more than 12 million people across the UK at risk of developing type 2 diabetes. Prevalence rates are still rising, so there’s obviously a lot of work to be done.”

Cities Changing Diabetes programme drives awareness, education and treatment; and aims to unite key community stakeholders to unite and work together to improve the lives and health outcomes of people with diabetes.

Leicester now joins the likes of Rome, Copehnagan, Shanghi, Houston, Johannesburg, Mexico City, Shanghai, Tianjin and Vancouver to begin a global mission to reduce the prevalence of diabetes.

A hand-picked team of diabetes experts and researchers from the Leicester Diabetes Centre have joined forces to work collectively with stakeholders and partners on the Leicester Changing Diabetes initiative.

Professor Kamlesh Khunti, Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and Co-Director at Leicester Diabetes Centre, added: “We firmly believe the Cities Changing Diabetes programme here in Leicester will be a major boost to help us drive positive environmental changes that could reduce the risk of developing type 2 diabetes, as well as ensure those with the condition have the right level of support and education to manage it properly.”

Diabetes UK’s figures also suggest there are now almost 3.7 million people living with a diagnosis of the condition in the UK, an increase of 1.9 million since 1998.

Launched in 2014, Cities Changing Diabetes is a partnership programme initiated by the pharmaceutical company Novo Nordisk, University College London and Steno Diabetes Center Copenhagen to innovate new approaches to the prevention and management of type 2 diabetes in urban areas.

Founded in 2003, LDC is responsible for world-leading clinical research, evidence-based education and cutting-edge innovation.

Based at Leicester General Hospital, it is a partnership between Leicester’s Hospitals and the University of Leicester.

ENDS

Share this page: